Abstract
Neoplasms in the fetus and infant are discussed in reference to types, incidence, clinical features, behavior, and response to treatment. Tumors that occur predominately in the first year of life have certain features of embryonic growth, including Wilms’ tumors, neuroblastomas, embryonic sarcomas, yolk sac tumors of the testis, hepatoblastomas, and medulloblastomas of the brain, as well as sacrococcygeal tumors that have an overgrowth of embryonic components. Chromosome translocations, tumor suppressor genes, and some syndromes and congenital malformations associated with childhood tumors are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ARMS:
-
Alveolar rhabdomyosarcoma
- BWS:
-
Beckwith-Wiedemann syndrome
- CHEK2:
-
Checkpoint kinase 2
- CN:
-
Cystic nephroma
- CNS:
-
Central nervous system
- ERMS:
-
Embryonal rhabdomyosarcoma
- EWS:
-
Ewing sarcoma
- FAP:
-
Familial adenomatous polyposis
- FISH:
-
Fluorescent in situ hybridization
- GIST:
-
Gastrointestinal stromal tumors
- HPV:
-
Human papilloma virus
- IGF2:
-
Insulin-like growth factor II
- MEN1:
-
Multiple endocrine neoplasia type 1
- MEN2:
-
Multiple endocrine neoplasia type 2
- NF1:
-
Neurofibromatosis type 1
- NF2:
-
Neurofibromatosis type 2
- PDGF:
-
Platelet-derived growth factor
- PNET:
-
Primitive neuroectodermal tumor
- PTCH:
-
Patch
- RT-PCR:
-
Reverse transcription-polymerase chain reaction
- SHH:
-
Sonic hedgehog
- SMO:
-
Smoothened
- VHL:
-
Von Hippel-Lindau
- WAGR syndrome:
-
Wilms’ tumor, aniridia, genitourinary abnormalities and mental retardation
- WT-1:
-
Wilms’ tumor-1 gene product
References
Bader JL, Miller RW (1979) US cancer incidence and mortality in the first year of life. Am J Dis Child 133:157–159
Bolande RP (1971) Benignity of neonatal tumors and concept of cancer repression in early life. Am J Dis Child 122:12–14
Bolande RP (1976) Neoplasia of early life and its relationships to teratogenesis. Perspect Pediatr Pathol 3:145–183
Crist W, Pullen J, Boyett J, Falletta J, van Eys J, Borowitz M, Jackson J, Dowell B, Frankel L, Quddus F et al (1986) Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Blood 67:135–140
Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW (1986) Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58(2 Suppl):598–602
Gilbert-Barness E (ed) (2007) Potter’s pathology of the fetus, infant and child, 2nd edn. Mosby-Elsevier, Philadelphia
Reaman G (1993) Special considerations for the infant with cancer, 2nd edn. Lippincott, Philadelphia
Reaman G, Zeltzer P, Bleyer WA, Amendola B, Level C, Sather H, Hammond D (1985) Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. J Clin Oncol 3:1513–1521
Willis RA (1962) The borderland of embryology and pathology. Butterworths, London
Fernbach DJ, Vietti TJ (1991) General aspects of childhood cancer, 3rd edn. Mosby, St. Louis
Isaacs HJ (1993) Tumors of the fetus and infant-an atlas. Springer, New York
Berry PJ (1993) Congenital tumors, 2nd edn. Springer, Berlin
Broadbent VA (1992) Malignant disease in the neonate, 2nd edn. Churchill Livingstone, Edinburgh
Gale GB, D'Angio GJ, Uri A, Chatten J, Koop CE (1982) Cancer in neonates: the experience at the children’s hospital of Philadelphia. Pediatrics 70:409–413
Isaacs H Jr (1983) Neoplasms in infants: a report of 265 cases. Pathol Annu 18(Pt 2):165–214
Werb P, Scurry J, Ostor A, Fortune D, Attwood H (1992) Survey of congenital tumors in perinatal necropsies. Pathology 24:247–253
Mulvihill JJ (1993) Childhood cancer environment and hereditary, 2nd edn. JB Lippincott, Philadelphia
Isaacs H Jr (2007) Introduction to tumors. In: Gilbert-Barness E (ed) Potter’s pathology of fetus, infant and child, 2nd edn. Elsevier, Philadelphia
Isaacs H Jr (1997) Tumors. In: Gilbert-Barness E (ed) Potter’s pathology of fetus, infant and child. Mosby Year Book, Philadelphia
Lengauer C (2003) Cancer. An unstable liaison. Science 300:442–443
Kinzler KW, Vogelstein B (2001) Familial cancer syndromes the role of caretakers an gatekeepers, 8th edn. McGraw-Hill, New York
Feinberg AP (2004) The epigenetics of cancer etiology. Semin Cancer Biol 14:427–432
Falls JG, Pulford DJ, Wylie AA, Jirtle RL (1999) Genomic imprinting: implications for human disease. Am J Pathol 154:635–647
Hall JG (1990) Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 46:857–873
Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM (2000) CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486–489
Barlow DP (1994) Imprinting: a gamete’s point of view. Trends Genet 1994(10):194–199
Villavicencio EH, Walterhouse DO, Iannaccone PM (2000) The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet 67:1047–1054
Hooper JE, Scott MP (2005) Communicating with hedgehogs. Nat Rev Mol Cell Biol 6:306–317
Yuspa SH, Epstein EH Jr (2005) Cancer. An anchor for tumor cell invasion. Science 307:1727–1728
Meder D, Simons K (2005) Cell biology. Ras on the roundabout. Science 307:1731–1733
Fodde R, Smits R (2002) Cancer biology. A matter of dosage. Science 298:761–763
Wilkin F, Gagne N, Paquette J, Oligny LL, Deal C (2000) Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. J Clin Endocrinol Metab 85:2048–2056
Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR (2005) The pathophysiology of HOX genes and their role in cancer. J Pathol 205:154–171
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323–331
Guo W, Giancotti FG (2004) Integrin signaling during tumour progression. Nat Rev Mol Cell Biol 5:816–826
Knudson AG Jr (1986) Genetics of human cancer. Annu Rev Genet 20:231–251
Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025–1032
DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP (2002) Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70:604–611
McTaggart SJ, Algar E, Chow CW, Powell HR, Jones CL (2001) Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 16:335–339
Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L et al (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447
Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L (2000) Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms’ tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 18:2026–2031
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH et al (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60:509–520
Haber DA, Englert C, Maheswaran S (1996) Functional properties of WT1. Med Pediatr Oncol 27:453–455
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778
Gashler AL, Bonthron DT, Madden SL, Rauscher FJ 3rd, Collins T, Sukhatme VP (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984–10988
Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ 3rd (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674–678
Morrison DJ, English MA, Licht JD (2005) WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res 65:8174–8182
Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF et al (1985) Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 317:260–262
Fraizer GE, Bowen-Pope DF, Vogel AM (1987) Production of platelet-derived growth factor by cultured Wilms’ tumor cells and fetal kidney cells. J Cell Physiol 133:169–174
Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE (1992) Expression of the PAX2 gene in human fetal kidney and Wilms’ tumor. Cell Growth Differ 3:279–289
Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791–4795
Feinberg AP (1996) Multiple genetic abnormalities of 11p15 in Wilms’ tumor. Med Pediatr Oncol 27:484–489
Li M, Squire JA, Weksberg R (1997) Molecular genetics of Beckwith-Wiedemann syndrome. Curr Opin Pediatr 9:623–629
Huff V, Amos CI, Douglass EC, Fisher R, Geiser CF, Krill CE, Li FP, Strong LC, McDonald JM (1997) Evidence for genetic heterogeneity in familial Wilms’ tumor. Cancer Res 57:1859–1862
Rahman N, Abidi F, Ford D, Arbour L, Rapley E, Tonin P, Barton D, Batcup G, Berry J, Cotter F et al (1998) Confirmation of FWT1 as a Wilms’ tumour susceptibility gene and phenotypic characteristics of Wilms’ tumour attributable to FWT1. Hum Genet 103:547–556
Gilbert-Barness EF (ed) (1998) Potter’s atlas of developmental and infant pathology. Mosby Year Book, Philadelphia
Sebire NJ, Malone M, Ashworth M, Jacques TS (2010) Diagnostic pediatric surgical pathology. Churchill-Livingstone/Elsevier, Philadelphia
Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ (2000) Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol 13:29–36
Schwab M, Westermann F, Hero B, Berthold F (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4:472–480
Ara T, DeClerck YA (2006) Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25:645–657
Lastowska M, Cullinane C, Vriend S, Cotterill S, Brown N, O’Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS, United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group (2001) Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 19:3080–3090
Shimada H (2003) The international neuroblastoma pathology classification. Pathologica 95:240–241
Gilbert-Barness E (2007) Potter’s pathology of the fetus, infant and child, vol 1 and 2, 2nd edn. Elsevier, Philadelphia
Peuchmaur M, d’Amore ES, Joshi W, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H (2003) Revision of the international neuroblastoma pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98:2274–2281
Lakhani VT, You YN, Wells SA (2007) The multiple endocrine neoplasia syndromes. Annu Rev Med 58:253–265
Tognon C, Knezevich SR, Huntsman D et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367–376
Rajan PB, Cranor ML, Rosen PP (1998) Cytosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol 22:64–69
Barrio AV, Clark BD, Goldberg JI et al (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14:2961–2970
Pelizzo G, Conoscenti G, Kalache KD et al (2003) Antenatal manifestation of congenital pancreatoblastoma in a fetus with Beckwith-Wiedemann syndrome. Prenat Diagn 23:292–294
Eberhart CG, Kepner JL, Goldthwaite PT et al (2004) Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol 63:441–449
Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW (2004) Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 10:5482–5493
Isaacs H Jr (1997) Tumors. In: Gilbert-Barness EF (ed) Potter’s pathology of the fetus and infant. Mosby Year Book, Philadelphia
Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720–723
Wu NF, Kushnick T (1974) The Beckwith-Wiedemann syndrome. The exomphalos-macroglossia-gigantism syndrome. Clin Pediatr (Phila) 13:452–457
Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665–667
Dao D, Walsh CP, Yuan L, Gorelov D, Feng L, Hensle T, Nisen P, Yatnashiro DJ, Bestor TH, Tycko B (1999) Multipoint analysis of human chromosome 11p15/mouse digital chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms’ tumorigenesis and methylation hyper-dependence of H19 imprinting. Hum Mol Genet 8:1337–1352
Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg S, Oshimura M, Feinberg AP (1999) Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc Natl Acad Sci USA 96:5203–5208
Morison IM, Reeve AE (1998) A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum Mol Genet 7:1599–1609
Onyango P, Miller W, Lehoczky J, Leung CT, Birren B, Wjeelan S, Dewar K, Feinberg AP (2000) Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain. Genome Res 10:1697–1710
Paulsen M, Davies KR, Bowden LM, Villar AJ, Franck I, Fuermann M, Dean WL, Moore TF, Rodrigues N, Davies KE et al (1998) Syntenic organization of the mouse distal chromosome 8 imprinting cluster and the Beckwith-Wiedemann syndrome region in chromosome 11p15.5. Hum Mol Genet 7:1149–1159
Xin Z, Soejima H, Higashimoto K, Yatsuki H, Zhu X, Satoh Y, Miasaki Z, Kaneko Y, Jimo Y, Fukuzawa R et al (2000) A novel imprinted gene, KCNQ1DN, within the WT2 critical region of human chromosome 11p15.5 and its reduced expression in Wilms’ tumors. J Biochem (Toyko) 128:847–853
Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Faryniarz AG, Chao MV, Huson S, Korf BR, Parry DM, Pericak-Vance MA et al (1987) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49:589–594
Listernick R, Charrow J, Gutmann DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38–44
Evans DG, Birch JM, Ramsden RT (1999) Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81:496–499
Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, Sampson JR (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome. Nat Genet 8:328–332
Crino PB, Nathanson KL, Henskie EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–1356
Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness EG (2004) Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal Pediatr Pathol 23:241–249
Cavenee WK (1997) Turcot syndrome. International Agency for Research on Cancer, Lyon
Schofield D, West DC, Anthony DC, Marshal R, Sklar J (1995) Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 146:472–480
Cowan R, Hoban P, Kelsey A, Birch JM, Gattamaneni R, Evans DG (1997) The gene for the nevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 76:141–145
Wiestler OD, Kleihues P, Vital A, Padberg GW (1997) Cowden disease and dysplastic gangliocytoma of the cerebellum/Lhermitte-Duclos disease. International Agency for Research on Cancer, Lyon
Marsh D, Zori R (2002) Genetic insights into familial cancers-update and recent discoveries. Cancer Lett 181:125–164
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gilbert-Barness, E., Eisbrenner, K. (2014). Molecular Pathology and Diagnostics of Childhood Tumors. In: Coppola, D. (eds) Molecular Pathology and Diagnostics of Cancer. Cancer Growth and Progression, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7192-5_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-7192-5_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7191-8
Online ISBN: 978-94-007-7192-5
eBook Packages: MedicineMedicine (R0)